Navigation Links
Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
Date:6/15/2011

ook for 2011

The agreement with Boehringer Ingelheim is expected to positively affect Zealand Pharma's revenues and other income by a total of DKK 150 (€20) million in 2011 but will not change the guidance on total operating expenses of DKK 170 (€23) million. Since Zealand Pharma's revenues stem from activity and success related milestone payments from partners, Zealand Pharma does not provide full year guidance on total revenues.

Zealand Pharma Conference call

Today, at 11:00am CET/ 10:00am BST/ 5:00am EST, Zealand Pharma will host a conference call, where David H. Solomon, President and Chief Executive Officer, will present this announcement. Mats Blom, Chief Financial Officer, and Hanne Leth Hillman, Vice President and Head of IR and Corporate Communications, will also participate in the call which will include a Q&A session.  The conference call will be conducted in English and the dial-in numbers are:

Denmark: +45-38-48-75-33

Europe:  +44(0)20-7138 0825

US:  +1-212-444-0481        

Confirmation Code: 4468737

About ZP2929

The biological rationale for developing ZP2929 is based on the pharmacology of the gut peptide hormone oxyntomodulin. Oxyntomodulin is released by the L-cells of the small intestine after meals, and is believed to exert its biological effects by activating both the glucagon receptor and the GLP-1 receptor. In humans, this hormone is believed to have multiple beneficial effects on diabetes and obesity, improving glucose tolerance and causing substantial weight loss.

ZP2929, which acts on both the glucagon and GLP-1 receptors, has shown in preclinical studies the ability to achieve glycemic control while causing significant and sustained weight loss. ZP2929 is being developed for once-daily subcutaneous administration to improve glycemic control and induce weight loss in patients with Type
'/>"/>

SOURCE Zealand Pharma A/S
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NxStage® Advances Global Growth Strategy with System One™ Regulatory Approval and Distribution Agreement in Australia and New Zealand
2. Prostate Cancer Patients Benefit from New Zealand Centers Adoption of Elekta VMAT Radiotherapy Technique
3. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
4. Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market
5. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
6. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
7. Saint-Gobains New C-Flex® ULTRA Pump Tubing for Biopharmaceutical Applications Outperforms the Competition
8. Inovio Pharmaceuticals to Present at Scientific & Industry Conferences
9. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
10. Caraco Announces Stockholder Approval of Merger Agreement with Sun Pharma and Consummation of the Merger
11. Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 ... announced the addition of the  "Global Freeze ... Industrial) Market - Forecast to 2019"  report ... http://photos.prnewswire.com/prnh/20130307/600769) ,The global freeze drying market was ... is expected to reach at $2,655.9 million ...
(Date:9/22/2014)... Children,s National Health System has announced ... 5 p.m. EDT for its "Make Your Medical ... continued strong interest from inventors.  Two ... to the winning presentations at the Sheikh Zayed Institute ... Children,s National in October. For competition details,  click ...
(Date:9/22/2014)... SHANGHAI , Sept. 22, 2014 /PRNewswire/ ... knowledge leader in healthcare technology, media and telecommunications, ... innovation in China and ... Continua and BHG announced this new partnership during ... week in Washington, DC , ...
Breaking Medicine Technology:Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 2Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 3Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... 30, 2011 Itchy, runny nose, sneezing, watery eyes ... that can make our children miserable from allergies. And ... the peak allergy season, PediaCare® , a trusted ... of a century, is introducing new one-dose per day, ...
... 2011 MonoSol Rx, the developers of PharmFilm® ... proprietary pharmaceutical film products, today announced that it ... the U.S. Food and Drug Administration (FDA) regarding ... (OSF) under a 505(b)(2) pathway.  The registration dossier ...
Cached Medicine Technology:Allergy Relief Moms Can Rely On 2MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film 2MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film 3
(Date:9/22/2014)... 2014 (HealthDay News) -- All sexually active women ... common sexually transmitted infections: chlamydia and gonorrhea, according ... Task Force. The task force noted ... 24 years of age and pregnant women. ... noticeable symptoms. As a result, many infections go ...
(Date:9/22/2014)... New York, New York (PRWEB) September 22, 2014 ... ) filed against Boston Scientific Corp. continue to ... underway in U.S. District Court, Southern District of ... court documents, a new Docket Control Order was ... addresses a number of matters pertaining to the ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... newborn intensive care units (NICU) set up private rooms for ... finds. Researchers at one children,s hospital found that preemies ... when their NICU switched from the traditional "open-bay" layout to ... 22 in the journal Pediatrics , add to evidence ...
(Date:9/22/2014)... Mozes HealthDay Reporter MONDAY, ... American parents are aware of online physician-rating sites, and more ... their children, according to a new national study. The ... -- further suggest that negative online ratings may dissuade parents ... recommended by a neighbor. Conversely, a positive online rating ...
(Date:9/22/2014)... whole eye transplant seems futuristic, if not impossible. ... Department of Defense, researchers at University of California, ... make implantation of an entire, functional eye a ... a holy grail for vision restoration," said Jeffrey ... co-recipient with colleagues at University of Pittsburg Medical ...
Breaking Medicine News(10 mins):Health News:Screen Women for Chlamydia, Gonorrhea, Experts Say 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 4Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Looking ahead: Whole eye transplant under development 2
... are getting forgetful as you get older, then a research ... School in the South West of England may have good ... such as blueberries, are effective at reversing age-related deficits in ... the science journal Free Radical Biology and Medicine. The ...
... April 10 - Entries for the eighth,annual Michael ... Biomedical Research (FBR) and named after FBR,s chairman, ... to all professional journalists whose reporting,has enhanced public ... the humane and responsible use of animal models., ...
... Systems To Expand ... Network, ... a focus on lower middle-market special situation,and deep value investments, announced today ... for Atlantic Street,Capital with a commitment from funds managed by the investment ...
... to significantly reduce total cost of ... ... Corp.,today announced that Chicago-based uBid, which helps sellers and,manufacturers liquidate excess ... to replace both its Oracle,E-Business Suite enterprise resource planning system and ...
... April 10 HEI, Inc. (Pink Sheets:,HEII; http://www.heii.com ... of fiscal year 2008, which ended March 1, 2008., ... compared to,$9,906,000 for the second quarter of fiscal year ... the second quarter of fiscal year,2008 compared to a ...
... 2008) On Wednesday, April 9, 2008, a symposium ... Experimental Biology was held in which noted scientists discussed ... randomized clinical trials (involving breastfeeding promotion) as well as ... into possible associations between infant feeding and health outcomes ...
Cached Medicine News:Health News:Getting forgetful? Then blueberries may hold the key 2Health News:DeBakey Awards to Recognize Excellence in Biomedical Research Journalism 2Health News:Atlantic Street Capital Announces First Close 2Health News:Asset-Recovery Leader Chooses Microsoft Dynamics AX and CRM Online 2Health News:Asset-Recovery Leader Chooses Microsoft Dynamics AX and CRM Online 3Health News:Asset-Recovery Leader Chooses Microsoft Dynamics AX and CRM Online 4Health News:Asset-Recovery Leader Chooses Microsoft Dynamics AX and CRM Online 5Health News:Asset-Recovery Leader Chooses Microsoft Dynamics AX and CRM Online 6Health News:HEI, Inc. Announces Results for the Second Quarter Fiscal 2008 2Health News:HEI, Inc. Announces Results for the Second Quarter Fiscal 2008 3Health News:HEI, Inc. Announces Results for the Second Quarter Fiscal 2008 4Health News:HEI, Inc. Announces Results for the Second Quarter Fiscal 2008 5Health News:New studies add insights to infant feeding and obesity issue 2Health News:New studies add insights to infant feeding and obesity issue 3
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: